ArticleProstate cancer and prostatic diseases2016

Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells.

S Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.